EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Risk factors for taxane‐induced peripheral neuropathy in patients with breast cancer

Cuilv Liang iD, Yin Zhang, Qi Ying Chen, Wen Fa Chen, Ming Zhu Chen

Asia-Pacific Journal of Clinical Oncology · 2024

DOI: 10.1111/ajco.13923 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Asia-Pacific Journal of Clinical Oncology, 2024. Verfasst von Cuilv Liang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Second Affiliated Hospital, Fujian Medical University, Quanzhou, China. Hauptthemen laut MEDLINE: Breast Neoplasms, Hypocalcemia, Peripheral Nervous System Diseases, Bridged-Ring Compounds. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study investigated the clinical risk factors for peripheral neuropathy induced by docetaxel and albumin‐bound paclitaxel (AP) in patients with breast cancer.

Methods

This prospective observational study recruited 268 patients between March 2019 and December 2020. Patient information was obtained through the query system for laboratory test results, patient consultations, and scale evaluations. Neuropathic symptoms were followed up throughout and until 3 months after taxane chemotherapy. Univariate and multivariate analyses were used to find the risk factors for overall and moderate–severe taxane‐induced peripheral neuropathy (TIPN).

Results

Cumulative dose (odds ratio [OR] = 3.533, 95% confidence interval [CI]: 1.797–6.944, p < 0.001), body mass index (BMI) (OR = 2.926, 95% CI: 1.621–5.281, p < 0.001), body surface area (BSA) (OR = 1.724, 95% CI: 1.011–2.941, p = 0.045), and hypocalcemia (OR = 4.899, 95% CI: 1.518–15.811, p = 0.008) all increased the risk of TIPN. Only cumulative dose (OR = 2.577, 95% CI: 1.161–5.719, p = 0.020) and BSA (OR = 2.040, 95% CI: 1.073–3.877, p = 0.030) were independent risk factors for moderate–severe TIPN.

Conclusion

Cumulative dose, BMI, BSA, and hypocalcemia are all risk factors for overall TIPN, whereas cumulative dose and BSA are risk factors for moderate–severe TIPN. Patients with breast cancer who have high BMI, large BSA, hypocalcemia, and large cumulative dose may be at risk of TIPN, and intervention measures must be actively carried out for them.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHypocalcemiaPeripheral Nervous System DiseasesBridged-Ring CompoundsHumansFemalePaclitaxelTaxoidsRisk Factors

Substanzen

PaclitaxeltaxaneTaxoidsBridged-Ring Compounds

Autor:innen und Institutionen

  • Department of Pharmacy, Second Affiliated Hospital, Fujian Medical University, Quanzhou, China.
  • Department of Pharmacy, Quan Zhou Medical College, Quanzhou, China.

ORCID-Profile: Cuilv Liang

Zitieren

APA

Liang, C., Zhang, Y., Chen, Q. Y., Chen, W. F., & Chen, M. Z. (2024). Risk factors for taxane‐induced peripheral neuropathy in patients with breast cancer. Asia-Pacific Journal of Clinical Oncology. https://doi.org/10.1111/ajco.13923

Vancouver

Liang C, Zhang Y, Chen QY, Chen WF, Chen MZ. Risk factors for taxane‐induced peripheral neuropathy in patients with breast cancer. Asia-Pacific Journal of Clinical Oncology. 2024. doi:10.1111/ajco.13923

BibTeX
@article{Liang2024,
  author = {Liang, Cuilv and Zhang, Yin and Chen, Qi Ying and Chen, Wen Fa and Chen, Ming Zhu},
  title = {Risk factors for taxane‐induced peripheral neuropathy in patients with breast cancer},
  journal = {Asia-Pacific Journal of Clinical Oncology},
  year = {2024},
  doi = {10.1111/ajco.13923}
}
Kostenlos starten →